Content: UDCA (trade names: Ursoliv, Ursosan, Urcevel) possesses the ability to reduce cholesterol secretion into bile, inhibits intestinal cholesterol absorption, dissolves gallstones by breaking down the cholesterol, and lowers the production of cholesterol by liver.

Conclusion: All of these effects allow UDCA to be used in an integrated treatment of hypercholesteremia. Plus, UDCA provides additional protection to hepatobiliary system of a human body.

Reference: F. Komarov, M. Osadchuk, A. Osadchuk (2010). "Practical gastroenterology. Part III. Diseases of gallbladder and bile ducts". 207.